Institutional investors purchased a net $4.1 million shares of ILMN during the quarter ended December 2015 and now own 100.34% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 2.7 Million shares of Illumina Inc
THE VANGUARD GROUP, INC. Bought 2.5 Million shares of Illumina Inc
NEW YORK STATE TEACHERS RETIREME... Bought 215.6 Thousand shares of Illumina Inc